Vistin Pharma ASA : Energy trading business to commence operations

Oslo, Norway, 8 May 2018

Reference is made to the announcements from Vistin Pharma ASA on 16 March and
22 March regarding the development of a new business area within energy trading.
At the annual general meeting held today the shareholders approved the required
changes to the articles of association. The shareholders also approved the
private placement of NOK 300 million in gross proceeds completed on 22 March, to
fund the establishment of the energy trading business and trading activities
within this area. Part of Vistin Pharma's strategy is to invest in asymmetrical
investment opportunities caused by fundamental changes in the oil space, and the
Company is now in a position to commence its trading activities. Vistin Pharma
plans to invest in energy related financial instruments in the near future,
which is expected to create a significant financial exposure. The total
financial exposure of these investments will not exceed the capital raised to
fund the energy trading activity. All trading activities will be carried out
through the wholly owned subsidiary Vistin Trading AS.


For further information, please contact:

Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com



This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.